Skip to content 
Pharmaceutical Litigation
Depo-Provera Acquisition
One of the most closely watched pharmaceutical torts in the market.
Why Depo-Provera Matters Right Now
Depo-Provera has become one of the most closely watched pharmaceutical torts in the market. Law firms pursuing this category are looking closely at claims involving long-term use and severe injury allegations, making it a major area of interest for firms expanding their tort practice.
For firms evaluating newer opportunities, Depo-Provera stands out because it combines a compelling injury story with strong consumer recognition and growing legal attention.
We focus on qualifying claimants against MDL-specific exposure timelines and medical history, ensuring your intake team only handles case-ready claims.
What You Get
MDL-specific exposure timeline qualification
Medical and prescription history captured
Nurse-led intake for sensitive medical detail
TCPA and HIPAA compliant end-to-end
The Depo-Provera and Meningioma Connection
Depo-Provera is a long-acting injectable contraceptive containing medroxyprogesterone acetate. While effective for contraception and conditions like endometriosis and abnormal uterine bleeding, ongoing safety monitoring has linked extended use to the development of meningiomas – typically benign brain tumors that can still cause significant neurological symptoms.
Recent research indicates that prolonged use of Depo-Provera, particularly for five years or more, may increase the risk of developing meningiomas. Plaintiffs argue that manufacturers failed to adequately warn consumers about this potential risk.
Common Symptoms We Capture at Intake
Persistent or worsening headaches
Seizures or new-onset neurological symptoms
Blurred vision or vision loss
Changes in mental status or personality
Weakness, numbness, or balance and coordination issues
Where the Litigation Stands
Courts have allowed cases to proceed past initial motions to dismiss, signaling willingness to examine the scientific evidence more closely. Several jurisdictions have moved toward consolidating similar cases to streamline proceedings and facilitate potential settlements.
For plaintiff firms, this means now is the time to build a serious Depo-Provera docket – with claimants who meet the duration-of-use, diagnosis, and timing criteria the litigation requires.
Qualification & Screening Criteria
Documented Depo-Provera use, with preference for five or more years
Diagnosed meningioma or qualifying brain tumor
Diagnosis timing aligned with current MDL criteria
Medical records and prescription history available for review
What You Receive
Pre-qualified, MDL-ready Depo-Provera claimants
Nurse-led intake on sensitive medical history
Audit-ready consent and chain-of-custody documentation
Replacement support on unqualified claims
Other Featured Mass Torts
Explore the rest of our current top mass tort opportunities.
Asbestos Litigation
Mesothelioma
One of the most established mass tort categories, mesothelioma offers strong case value and consistent demand from individuals and families seeking representation.
PRODUCT LIABILITY
Hair Relaxer
One of the most visible product liability categories, with strong public familiarity and emotional resonance behind the claim story.
GLP-1 PHARMACEUTICAL LITIGATION
Ozempic
Public awareness of GLP-1 medications continues to drive consumer response and strong campaign performance.
Ready to Build Your Depo-Provera Docket?
We limit participating firms per tort to protect inventory quality. Reach out to discuss campaign structure and acquisition goals.